Shanghai Obio Technology (Group) Corp., Ltd. (SHA:688238)

China flag China · Delayed Price · Currency is CNY
6.60
-0.19 (-2.80%)
At close: May 12, 2026
Market Cap4.28B +27.8%
Revenue (ttm)265.39M +9.9%
Net Income-228.67M
EPS-0.36
Shares Out630.31M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume13,258,944
Average Volume9,437,793
Open6.81
Previous Close6.79
Day's Range6.57 - 6.81
52-Week Range5.54 - 9.20
Beta0.55
RSI41.84
Earnings DateApr 21, 2026

About SHA:688238

Shanghai Obio Technology (Group) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and anti-aging in China. The company offers customized plasmid design and viral vector packaging services; AAV serotypes and tissue-specific promoters to support scientific research; and research grade, NHP Grade, cGMP grade vector manufacturing process, for basic research, translational research and clinical trials. It also provides CDMO services encompassing process development, analytica... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 678
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688238
Full Company Profile

Financial Performance

In 2025, SHA:688238's revenue was 267.70 million, an increase of 7.88% compared to the previous year's 248.15 million. Losses were -235.06 million, -26.96% less than in 2024.

Financial Statements